VIA

VIA® PRODUCTS

The VIA® cellular bone matrices are viable allogeneic bone allografts intended for use in bone remodeling. Each VIA product contains the three key elements that are ideal for bone formation:

• An osteoconductive three-dimensional scaffold with cortical and cancellous components.

• A demineralized bone scaffold with osteoinductive potential which provides exposure of signaling molecules and bone morphogenetic proteins.1

• Bone-derived cells to support osteogenic healing processes.

The VIA product line is prepared with a novel DMSO-free cryoprotectant, which provides dependable cell identity and the ability to sustain cell viability post-thaw. Final preparation of the cell and bone components yields a product that provides osteoconductive, osteoinductive, and osteogenic properties to enhance the patient’s innate healing response.

VIA GRAFT AND VIA GRAFT MOLDABLE 

The bone scaffold component of VIA Graft and VIA Graft Moldable combines a proprietary mixture of 100-300 µm demineralized cortical bone and mineralized cortical and cancellous bone. Final preparation of the VIA Graft microparticulate scaffold and cell mixture allows for tight packing of a defect with a cohesive wet sand consistency. Final preparation of the VIA Graft Moldable microparticulate scaffold and cell mixture facilitates a biologic allograft that retains features consistent with a cohesive allograft with hydrophobic properties that resist lavage.

VIA FORM AND VIA FORM MOLDABLE 

The bone scaffold component of VIA Form and VIA Form Moldable is a proprietary mixture of cortical shavings, crushed cancellous chips, and 100–300 μm demineralized cortical bone microparticulate. The VIA Form bone particulate scaffold allows for a more cohesive fibrous consistency upon implantation. Final preparation of the VIA Form Moldable microparticulate scaffold and cell mixture allows for a cohesive, fibrous, moldable allograft with hydrophobic properties that is resistant to lavage.

KEY Features

• Four (4) unique scaffold blends for optimal handling characteristics: VIA Graft, VIA Graft Moldable, VIA Form, VIA Form Moldable.

• Proprietary, optimized bone microparticulate size range of 100-300 µm.2

• Novel DMSO-free cryoprotectant, with no rinsing and decanting steps required prior to use.

• Convenient handling and preparation in the OR, with total preparation time on the back table less than 20 minutes.

• Four (4) hour working window for implantation after thaw without loss of cell viability.

• Product shelf-life is two (2) years from date of processing when stored at -65°C or colder.

Potential Clinical Applications

• Spine

• Upper Extremity

• Foot and Ankle

• Oral and Maxillofacial

• Orthopaedic Oncology

via graft moldable

[SIZE]•CODE
[2.5cc]•VCAX-025000
[5.0cc]•VCAX-050000
[10.0cc]•VCAX-100000